WO2017013682A1 - Process of preparation of co-processed polymer and it's pharmaceutical application - Google Patents

Process of preparation of co-processed polymer and it's pharmaceutical application Download PDF

Info

Publication number
WO2017013682A1
WO2017013682A1 PCT/IN2016/050244 IN2016050244W WO2017013682A1 WO 2017013682 A1 WO2017013682 A1 WO 2017013682A1 IN 2016050244 W IN2016050244 W IN 2016050244W WO 2017013682 A1 WO2017013682 A1 WO 2017013682A1
Authority
WO
WIPO (PCT)
Prior art keywords
gum
processed polymer
cpg
property
processed
Prior art date
Application number
PCT/IN2016/050244
Other languages
French (fr)
Inventor
Harshal Ashok PAWAR
Swati Ramesh KAMAT
Pritam Dinesh CHOUDHARY
Amit Jagannath GAVASANE
Paraag GIDE
Original Assignee
Pawar Harshal Ashok
Kamat Swati Ramesh
Choudhary Pritam Dinesh
Gavasane Amit Jagannath
Gide Paraag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pawar Harshal Ashok, Kamat Swati Ramesh, Choudhary Pritam Dinesh, Gavasane Amit Jagannath, Gide Paraag filed Critical Pawar Harshal Ashok
Publication of WO2017013682A1 publication Critical patent/WO2017013682A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0033Xanthan, i.e. D-glucose, D-mannose and D-glucuronic acid units, saubstituted with acetate and pyruvate, with a main chain of (beta-1,4)-D-glucose units; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0096Guar, guar gum, guar flour, guaran, i.e. (beta-1,4) linked D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from Cyamopsis Tetragonolobus; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02Cellulose; Modified cellulose

Definitions

  • the present invention relates to co-processed polymer of two or more natural polysaccharides.
  • the present invention also relates to a process of preparation thereof and applications in making various dosage forms.
  • GRAS Generally recognized as safe
  • the manufacturer has to perform all necessary research, including the formation of an expert panel to review safety concerns, and may have to prepare to use these findings to defend its product's GRAS status. Approval procedures are simplified if the new excipient is obtained from two known and safe excipients and without any chemical change. Also if particularly, one excipient has multifunctional role to play, it is more advantageous to develop such excipient.
  • An object of the present invention is to provide a co-processed polymer prepared from two or more natural polysaccharides.
  • Another object of the present invention is to provide various applications of such co-processed polymer prepared from two or more natural polysaccharides.
  • Yet another object of the present invention is to provide processes for preparation of co-processed polymer.
  • a co-processed polymer prepared from two or more natural polysaccharides.
  • the present invention provides the co-processed polymer of two or more natural polysaccharides which exhibits excellent physical properties as compared to individual gums and their physical mixtures.
  • the co-processed polymer has excellent physical properties as compared to individual polysaccharide or gum or mucilage and their physical mixtures.
  • the Carr's Index and angle of repose for the co-processed polymer is about 50% of that of its physical mixture implying excellent flow properties over their physical mixture.
  • Hausner ratio is below 1.25 and preferably below 1.2 and most preferably about 1.15 again implying excellent flow properties.
  • the co-processed polymer of the present invention has double the viscosity than the viscosity exhibited by physical mixture and swelling index is more than 500 %. This makes the co-processed polymer ideal binder and release retarding agent and it can be used in much lesser amounts than the amounts in which the gums are used for the said functions.
  • co-processed polymer of the present invention has good physical properties and can play multiple roles in various dosage forms.
  • Another aspect of the present invention is to provide applications of the co- processed polymer of xanthan gum and guar gum.
  • the co-processed polymer of the present invention improves the tablet hardness and friability.
  • the co-processed polymer provides an alternative to conventional binders.
  • the tablets have improved friability and thus resistant to normal wear and tear that takes place during transporting, handling, coating and packing.
  • the co-processed polymer also used to prepare sustained and extended release dosage forms, particularly tablets. Thus, it provides alternative to conventional release retard agents.
  • Yet another aspect of the present invention provides a process to prepare the co- processed polymer comprising two or more polysaccharides.
  • the process comprises the steps of a) dispersing or dissolving two or more natural polysaccharides (gums or mucilages) in water b) mixing the dispersion or solution till to get a homogenous solution c) precipitating the co-processed polymer using organic solvent selected from iso-propyl alcohol (IPA), ethanol or acetone d) collecting and drying the precipitate and e) optionally pulverizing the dried precipitate to get the co-processed polymer.
  • IPA iso-propyl alcohol
  • acetone organic solvent selected from iso-propyl alcohol (IPA), ethanol or acetone
  • Fig. 1 Overlapping of IR spectra of co-processed polymer of 1: 1 xanthan gum and guar gum and their physical mixture.
  • Fig. 2 Overlapping of DSC of co-processed polymer of 1: 1 xanthan gum and guar gum and their physical mixture.
  • the present invention relates to various co-processed polymers of two or more natural polysaccharides.
  • the polysaccharide is gum or mucilages which is selected from the group comprising Guar gum, Xanthan gum, Acacia gum, Karaya gum, Gum Ghatti, Locust bean gum, Okra gum, Albizia gum, Tara gum, Cassiatora, Cordia, Taro, Konjac, Isabgol mucilage, Phoenix mucilage, Jackfruit gum, Tamarind seed polysaccharide, Fenugreek mucilage, Honey locust gum, Mimosa scrabella, Mimosa pudica, Ocimum mucilage, Gum rosin, Black gram, Gulmohar mucilage, Almond gum, Cashew gum, Moringaoleifera gum, Gum damar, Gum Copal, Kondagogu Gum, Bhara gum, Hakea gum, Grewia gum, Olibanum gum, Terminalia gum, Cocculus mucilage, Aloe mucilage, Hibiscus
  • the two or more natural polysaccharides or gums are taken in any proportion from 1: 10 to 10: 1, preferably from 1:5 to 5: 1. The most suitable proportion is 1: 1.
  • Application of the co-processed polymer is described as follows.
  • the co-processing of the two or more polysaccharides or gums according to the present invention leads to a co-processed polymer that has improved flow property and compressibility. Hence, it is beneficial in compression of tablets.
  • the co- processed gum has enhanced swelling property compared to individual component gums and hence is beneficial as release retard agent.
  • such co-processed polymer enhances disintegration properties including reduction of disintegration time and improving disintegration pattern. Hence it is beneficial as a disintegrant for conventional oral solid dosage forms particularly tablets.
  • the co-processed polymers according to the present invention exhibit significantly enhanced physical properties over its individual components.
  • the significantly enhanced physical property is one or more of flow properties, disintegration property, compressibility, binding property, property to enhance hardness, viscosity, swelling property, gelling property, emulsifying property, suspending property, film forming property and sustained release property.
  • the flow properties of gums are usually undesirable.
  • the co-processing has dramatically improved the flow properties when compared with physical mixture of two or more gums.
  • the co-processed polymer prepared from 1 : 1 Xanthan gum and Guar gum according to the present invention is not only exhibited improved properties over mere physical mixture of the two or more gums, but also exhibited significant change in the physical properties as shown in Table 1 below.
  • the co- processed polymer has excellent flow properties, compressibility, hardness, viscosity, and swelling capacity as seen from data reported under i) Carr's Index ii) Hausner's ratio and iii) Angle of repose.
  • the co-processed polymer of the present invention imparts enhanced binding properties to the compositions. Enhanced binding is indicated by enhanced hardness and increase in disintegration time.
  • the binding capacity of the co-processed polymer is evaluated using high dose drug Venlafaxine HCl (around 37.5% of formulation) as exemplified under example 1.
  • This drug has poor compressibility and poor binding capacity.
  • the task was to produce tablets that have disintegration time of 8 to 10 min. As seen from example 1, 4 % of xanthan gum or 4 % of guar gum could not achieve the target disintegration time. Physical mixture of xanthan gum and guar gum produced tablets with better disintegration time however the co- processed polymer of two gums in the same concentration lowers the disintegration time many folds.
  • This experiment also reflects that if a disintegration time of 1 to 3 minute is desired, even 1 % concentration of co -processed polymer is sufficient. This will reduce the tablet weight or in other words, it can act as a binder in as low as 1% concentration for making tablet.
  • Gums impart quite variable disintegration times to their preparations. Usually, guar gum does not increase disintegration time but xanthan gum does. The present inventors have tested the capacity of co-processed polymer to act as a super disintegrating agent and whether it was able to produce an oral disintegrating tablet.
  • the oral disintegrating tablets of Ondansetron hydrochloride are prepared using up to 10 % of each of i) xanthan gum ii) guar gum iii) physical mixture (1: 1) and iv) co-processed polymer (1: 1).
  • the co-processed polymer could produce oral disintegrating tablet that disintegrated within 1 minute preferably within 30 seconds when it is used in dry form up to 10 % concentration.
  • the hardness of these tablets was better than the hardness of tablets produced from individual gums and their physical mixtures. Many a times hardness of oral disintegrating tablets poses a problem in that such tablet is brittle and difficult to handle while packing.
  • Example 2 shows that tablets containing CPG are compressed at hardness of 2 - 2.5 kg/cm 2 and they can disintegrate much faster.
  • the co-processed polymer of the present invention has dual action and is used as binder as well as disintegrants in pharmaceuticals. In wet granulation, it preferably acts as a binder whereas in direct compression it acts as a disintegrant. This provides flexibility to use same excipient in different ways.
  • the co-processed polymer according to the present invention exhibits significantly higher swelling index as compared to the physical mixture of the counterpart polysaccharides or gums or mucilages.
  • the co-processed polymer of xanthan gum and guar gum has 675 % swelling index (refer Table 1) as against 375 % swelling index of their physical mixture. This is an indication that it has capacity to act as a sustained release agent.
  • diclofenac tablets of 200 mg weight having diclofenac sodium (75 mg) are formulated using direct compression process with i) co-processed polymer (75 mg) and also ii) physical mixture of xanthan gum and guar gum.
  • the physical mixture having the same concentrations of xanthan gum and guar gum could not sustain the release of the drug diclofenac sodium while the co-processed polymer in the same amounts produced sustained action over 8 to 10 hrs. Surprisingly the direct compression process has produced this action. This may eliminate the need of granulation and save processing time and cost of production.
  • the gums are used in oral films along with other film forming polymers.
  • the film forming capacity of the co-processed polymer alone is tested.
  • the film forming capacity of the co-processed polymer test as exemplified under example 4 oral films of Ondansetron hydrochloride were prepared.
  • the co-processed polymer produced excellent oral films without use of any other polymer which dissolve in mouth instantly. These films released more than 85 % drug within 15 minutes and are stable.
  • the co-processed polymer also exhibits a gel forming capacity.
  • the co-processed polymer in amounts from 0.5 to 5 % can be soaked in water for 2 to 8 hrs to produce gels.
  • the soaked gel solution can be stirred to get desired homogeneity.
  • Drug can be dissolved in alcohol or hydroalcoholic solution or water and added to such gel while stirring and the co-processed polymer (2 %) soaked for 4 to 5 hours produced excellent gel upon little stirring.
  • a translucent gel of diclofenac sodium was produced having sufficient viscosity and spreadability.
  • the co-processed polymer has capacity of emulsification.
  • the resultant emulsions prepared using the co-processed polymer of the present invention are stable and free of odour of oil.
  • the example 6 wherein an oil/water emulsion is prepared in which arachis oil is emulsified using co-processed polymer and such emulsion is found stable for four hours.
  • stable water/oil emulsions using the co-processed polymer of the present invention can be prepared.
  • multifunctional polymer is successfully produced by co-processing two or more natural gums such as xanthan and guar gums preferably in a ratio of 1 : 1.
  • This co-processed polymer differs significantly in properties from the two natural gums. It can act as binder, disintegrant, sustained release agent, film forming agent, gel forming agent, suspending agent, emulsifier and can have more roles to play.
  • the co-processed polymers of the present invention serve as ideal excipients for use in excipient nutraceutical, pharmaceutical, biopharmaceutical, food, cosmetic, cosmeceutical, agrochemical compositions.
  • co-processed polymers of the present invention can be used as such in variety of preparations or they can be admixed with other excipients such as cellulose, starch, lactose, mannitol and likes to prepare excipient mixtures which are further employed in variety of preparations.
  • the process to prepare the co-processed polymer comprises 1) dispersing or dissolving two or more natural polysaccharides (gums or mucilages) in water 2) mixing the dispersion or solution till one gets a homogenous solution 3) precipitating the co-processed polymer using organic solvent selected from iso-propyl alcohol (IP A), ethanol and acetone 4) collecting and drying the precipitate and 5) optionally pulverizing the dried precipitate to get the desired co-processed polymer.
  • organic solvent selected from iso-propyl alcohol (IP A), ethanol and acetone
  • the process of preparation of the co-processed polymers is simple and economical.
  • the process incorporates precipitation of the co-processed polymers by using solvent /anti-solvent method which imparts unique properties to the co-processed polymers.
  • the process to prepare the co-processed polymers of two or more polysaccharides is performed at room temperature and thus has advantage over the hot melt method. Further, it is evident from the figures, fig. 1 and fig. 2 that there is no change in the chemical properties of the polysaccharides which confirms that there is no chemical interaction between the two polysaccharides.
  • the process to prepare co-processed polymer according to the present invention merely changes the physical properties of individual gums in such a way that the resultant co- processed polymers exhibit beneficial physical properties and can be used as multifunctional excipient.
  • the natural polysaccharide comprises gum or mucilage.
  • co-processed polymer or CPPor co-processed gum or CPG, as used herein, are interchangeably used and have the same meaning in the description.
  • the combination of gums used for making the co-processed polymer or co-processed gum is selected from the group comprising Xanthan gum and Guar gum (CPG XG), Xanthan gum and Acacia (CPG XA), Acacia and gum Karaya (CPG AK), Xanthan gum and gum Karaya (CPG XGKG), Guar gum and gum Karaya (CPG GK), Xanthan gum and gum Ghati (CPG XGh), Guar gum and gum Ghati (CPG GGh), Guar gum and Acacia (CPG GA) or gum Karaya and gum Ghati (CPG KGh).
  • the co-processed polymer is selected from the group comprising co-processed polymer of Xanthan gum and Guar gum (CPG XG), co-processed polymer of Xanthan gum and Acacia (CPG XA), co-processed polymer of Acacia and gum Karaya (CPG AK), co-processed polymer of Xanthan gum and gum Karaya (CPG XGKG), co-processed polymer of Guar gum and gum Karaya (CPG GK), co-processed polymer of Xanthan gum and gum Ghati (CPG XGh), co-processed polymer of Guar gum and gum Ghati (CPG GGh), co- processed polymer of Guar gum and Acacia (CPG GA) or co-processed polymer of gum Karaya and gum Ghati (CPG KGh).
  • CPG XG co-processed polymer of Xanthan gum and Guar gum
  • the drug which can be used for making oral disintegrating tablet is selected from the group comprising ondansetron hydrochloride, ibuprofen, lamotrigine, paracetamol, oxycodone, diclofenac, amlodipine, clonazepam, cetirizine, donepezil, risperidone, tramadol, alprazolam, carbidopa-levodopa, dipheniramine, prednisolone, zolmitriptan, selegiline, sildenafil citrate, vardenafil hydrochloride, tadalafil, mirtazapine, fexofenadine, imodium, famotidine, olanzapine, mirtazapine, loratadine, piroxicam, rizatriptan and likes.
  • ondansetron hydrochloride ibuprofen, lamotrigine, paracetamol, oxyco
  • the drug which can be used for making sustained release tablet is selected from the group comprising aceclofenac, chlorpheniramine maleate, metoprolol succinate, lornoxicam, nifedipine, metformin hydrochloride, diclofenac, glipizide, venlaflaxine hydrochloride, divalproex sodium, tramadol hydrochloride, lithium carbonate, quetiapine fumarate, clarithromycin, tamsulosine hydrochloride, amitriptyline hydrochloride, oxcarbazepine, amisulpriden, pregabalin, ranolazine, progesterone, etodolac, lamotrigine, valsartan and likes.
  • the drug which can be used for making film is selected from the group comprising curcumin, phenylephrine, levocetrizine, elitriptan, nifedipine, pilocarpine, propranolol, losartan potassium, venlafaxine, lamotrigine, tramadol, hydrochlorthiazide, famotidine, ondansetran hydrochloride, isosorbide dinitrated omperidone, ropinirole, granisetron, amlodipine, Zolpidem or ivabradine hydrochloride and likes.
  • curcumin phenylephrine
  • levocetrizine elitriptan
  • nifedipine pilocarpine
  • propranolol losartan potassium
  • venlafaxine lamotrigine
  • tramadol tramadol
  • hydrochlorthiazide famotidine
  • Formulation Tablet prepared using XG, GG and the co-processed polymer (CPG).
  • IPA Isopropyl alcohol
  • the drug, MCC and binder powder were weighed and thoroughly mixed. This mixture was then granulated by using IPA (q.s.) and granules were sieved through mesh size #10. Granules were dried in hot air oven at 50°C and then sieved through mesh size #20 and retained on mesh size #40. Magnesium stearate and talc were added. Tablets were punched on single press compression machine with 8 mm round, flat faced punch. Hardness was set around 4.
  • Starch paste (10%w/w) was added to bind the mixture and granules were sieved through mesh size #10. Quantity of starch powder in used starch paste was calculated. Granules were dried in hot air oven at 50° C and then sieved through mesh size #20 and retained on mesh size #40. Magnesium stearate and talc were added. Tablets were punched on single press compression machine with 8 mm round, flat faced punch. Hardness was set around 4.
  • Dissolution was performed in paddle type apparatus, RPM 50, bath temperature 37 degrees, dissolution medium- 900 ml phosphate buffer pH 7.5.
  • Dissolution was performed in paddle type apparatus, RPM 50, bath temperature 37 degrees, dissolution medium- 900 ml 0.1 N HCl.
  • CPG (2% w/w) solution in purified water was prepared by soaking the gum in water for 5 hours. This was then stirred a little to get homogenous consistency.
  • Diclofenac sodium (l%w/w) was dissolved in ethanol (1 ml) and added to the gel base. Viscosity was measured using Brookfield viscometer, using spindle no. 7 at 20 RPM.
  • the co-processed polymer is selected from the group comprising a co-processed polymer of Xanthan gum and Guar gum (CPG XG), co-processed polymer of Xanthan gum and Acacia (CPG XA), co-processed polymer of Acacia and gum Karaya (CPG AK), co-processed polymer of Xanthan gum and gum Karaya (CPG XK), co-processed polymer of Guar gum and gum Karaya (CPG GK), co-processed polymer of Xanthan gum and gum Ghati (CPG XGh), co-processed polymer of Guar gum and gum Ghati (CPG GGh), co-processed polymer of Guar gum and Acacia (CPG GA), co-processed polymer of gum Karaya and gum Ghati (CPG KGh) or co-processed polymer of Xanthan gum, Guar gum and Acacia (XGA). Vi
  • CPG co-processed gum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses co-processed polymer of one or more polysacharides useful for preparing the pharmaceutical dosage forms. The present invention also disclosed the process to prepare the co-processed polymer.

Description

Field of invention
The present invention relates to co-processed polymer of two or more natural polysaccharides. The present invention also relates to a process of preparation thereof and applications in making various dosage forms.
Background of the invention
Most formulations contain excipients at a higher concentration than the active pharmaceutical ingredient (API) and as a consequence excipients contribute critically towards processing, stability, safety and performance of solid dosage forms. The majority of the excipients that are currently available fail to meet the desired set of functionalities, therefore, creating urgency for the development of high functionality excipients. High functionality excipients can be obtained by developing new chemical excipients, improved grades of existing excipients, and new combinations of existing excipients. Developing a new chemical excipient is uneconomical and laborious from the stand point of safety and regulatory clearances. The primary reason for this lack of new chemical excipients is the relatively high cost involved in discovery and development of excipient. To categorize the newly developed excipient in "Generally recognized as safe" (GRAS) category, the manufacturer has to perform all necessary research, including the formation of an expert panel to review safety concerns, and may have to prepare to use these findings to defend its product's GRAS status. Approval procedures are simplified if the new excipient is obtained from two known and safe excipients and without any chemical change. Also if particularly, one excipient has multifunctional role to play, it is more advantageous to develop such excipient.
Object of the invention
An object of the present invention is to provide a co-processed polymer prepared from two or more natural polysaccharides.
Another object of the present invention is to provide various applications of such co-processed polymer prepared from two or more natural polysaccharides.
Yet another object of the present invention is to provide processes for preparation of co-processed polymer. Summary of the invention
According to an aspect of the present invention there is provided a co-processed polymer prepared from two or more natural polysaccharides.
In another aspect the present invention provides the co-processed polymer of two or more natural polysaccharides which exhibits excellent physical properties as compared to individual gums and their physical mixtures. The co-processed polymer has excellent physical properties as compared to individual polysaccharide or gum or mucilage and their physical mixtures. The Carr's Index and angle of repose for the co-processed polymer is about 50% of that of its physical mixture implying excellent flow properties over their physical mixture. Hausner ratio is below 1.25 and preferably below 1.2 and most preferably about 1.15 again implying excellent flow properties.
The co-processed polymer of the present invention has double the viscosity than the viscosity exhibited by physical mixture and swelling index is more than 500 %. This makes the co-processed polymer ideal binder and release retarding agent and it can be used in much lesser amounts than the amounts in which the gums are used for the said functions.
Thus, co-processed polymer of the present invention has good physical properties and can play multiple roles in various dosage forms. Another aspect of the present invention is to provide applications of the co- processed polymer of xanthan gum and guar gum. The co-processed polymer of the present invention improves the tablet hardness and friability. The co-processed polymer provides an alternative to conventional binders. The tablets have improved friability and thus resistant to normal wear and tear that takes place during transporting, handling, coating and packing. The co-processed polymer also used to prepare sustained and extended release dosage forms, particularly tablets. Thus, it provides alternative to conventional release retard agents. Yet another aspect of the present invention provides a process to prepare the co- processed polymer comprising two or more polysaccharides. The process comprises the steps of a) dispersing or dissolving two or more natural polysaccharides (gums or mucilages) in water b) mixing the dispersion or solution till to get a homogenous solution c) precipitating the co-processed polymer using organic solvent selected from iso-propyl alcohol (IPA), ethanol or acetone d) collecting and drying the precipitate and e) optionally pulverizing the dried precipitate to get the co-processed polymer. Brief description of the drawings
Fig. 1: Overlapping of IR spectra of co-processed polymer of 1: 1 xanthan gum and guar gum and their physical mixture.
Fig. 2: Overlapping of DSC of co-processed polymer of 1: 1 xanthan gum and guar gum and their physical mixture.
Description of the invention
The present invention relates to various co-processed polymers of two or more natural polysaccharides.
The polysaccharide is gum or mucilages which is selected from the group comprising Guar gum, Xanthan gum, Acacia gum, Karaya gum, Gum Ghatti, Locust bean gum, Okra gum, Albizia gum, Tara gum, Cassiatora, Cordia, Taro, Konjac, Isabgol mucilage, Phoenix mucilage, Jackfruit gum, Tamarind seed polysaccharide, Fenugreek mucilage, Honey locust gum, Mimosa scrabella, Mimosa pudica, Ocimum mucilage, Gum rosin, Black gram, Gulmohar mucilage, Almond gum, Cashew gum, Moringaoleifera gum, Gum damar, Gum Copal, Kondagogu Gum, Bhara gum, Hakea gum, Grewia gum, Olibanum gum, Terminalia gum, Cocculus mucilage, Aloe mucilage, Hibiscus mucilage, Neem gum, Moi gum, Konjacglucomannan, Curdlan gum, Gellan gum, Colanic acid or K30 antigen.
The two or more natural polysaccharides or gums are taken in any proportion from 1: 10 to 10: 1, preferably from 1:5 to 5: 1. The most suitable proportion is 1: 1. Application of the co-processed polymer is described as follows.
The co-processing of the two or more polysaccharides or gums according to the present invention leads to a co-processed polymer that has improved flow property and compressibility. Hence, it is beneficial in compression of tablets. The co- processed gum has enhanced swelling property compared to individual component gums and hence is beneficial as release retard agent. Interestingly it is noted that such co-processed polymer enhances disintegration properties including reduction of disintegration time and improving disintegration pattern. Hence it is beneficial as a disintegrant for conventional oral solid dosage forms particularly tablets.
The co-processed polymers according to the present invention exhibit significantly enhanced physical properties over its individual components. The significantly enhanced physical property is one or more of flow properties, disintegration property, compressibility, binding property, property to enhance hardness, viscosity, swelling property, gelling property, emulsifying property, suspending property, film forming property and sustained release property.
The flow properties of gums are usually undesirable. However, the co-processing has dramatically improved the flow properties when compared with physical mixture of two or more gums.
In one embodiment, the co-processed polymer prepared from 1 : 1 Xanthan gum and Guar gum according to the present invention is not only exhibited improved properties over mere physical mixture of the two or more gums, but also exhibited significant change in the physical properties as shown in Table 1 below. The co- processed polymer has excellent flow properties, compressibility, hardness, viscosity, and swelling capacity as seen from data reported under i) Carr's Index ii) Hausner's ratio and iii) Angle of repose.
Table 1 Properties Physical mixture CPG
Bulk density 0.568 0.576
Tapped density 0.78 0.6625
Carr' s index 27.179% 13%
Hausner's ratio 0.73 1.15
Angle of repose 20.89° 11°
Swelling index 375% 675%
Due to significant change in properties of the co-processed polymer, it is effective in very low amounts to produce the same or enhanced effect while in other cases, it produces an effect which cannot be produced by a mere physical mixture of two or more polysaccharides in any concentration.
The co-processed polymer of the present invention imparts enhanced binding properties to the compositions. Enhanced binding is indicated by enhanced hardness and increase in disintegration time.
In an embodiment of the present invention the binding capacity of the co-processed polymer is evaluated using high dose drug Venlafaxine HCl (around 37.5% of formulation) as exemplified under example 1. This drug has poor compressibility and poor binding capacity. The task was to produce tablets that have disintegration time of 8 to 10 min. As seen from example 1, 4 % of xanthan gum or 4 % of guar gum could not achieve the target disintegration time. Physical mixture of xanthan gum and guar gum produced tablets with better disintegration time however the co- processed polymer of two gums in the same concentration lowers the disintegration time many folds. This experiment also reflects that if a disintegration time of 1 to 3 minute is desired, even 1 % concentration of co -processed polymer is sufficient. This will reduce the tablet weight or in other words, it can act as a binder in as low as 1% concentration for making tablet.
Gums impart quite variable disintegration times to their preparations. Usually, guar gum does not increase disintegration time but xanthan gum does. The present inventors have tested the capacity of co-processed polymer to act as a super disintegrating agent and whether it was able to produce an oral disintegrating tablet.
In one embodiment as exemplified under example 2, the oral disintegrating tablets of Ondansetron hydrochloride are prepared using up to 10 % of each of i) xanthan gum ii) guar gum iii) physical mixture (1: 1) and iv) co-processed polymer (1: 1). The co-processed polymer could produce oral disintegrating tablet that disintegrated within 1 minute preferably within 30 seconds when it is used in dry form up to 10 % concentration. The hardness of these tablets was better than the hardness of tablets produced from individual gums and their physical mixtures. Many a times hardness of oral disintegrating tablets poses a problem in that such tablet is brittle and difficult to handle while packing. Example 2 shows that tablets containing CPG are compressed at hardness of 2 - 2.5 kg/cm2 and they can disintegrate much faster.
Thus, the co-processed polymer of the present invention has dual action and is used as binder as well as disintegrants in pharmaceuticals. In wet granulation, it preferably acts as a binder whereas in direct compression it acts as a disintegrant. This provides flexibility to use same excipient in different ways.
The co-processed polymer according to the present invention exhibits significantly higher swelling index as compared to the physical mixture of the counterpart polysaccharides or gums or mucilages. In an embodiment, the co-processed polymer of xanthan gum and guar gum has 675 % swelling index (refer Table 1) as against 375 % swelling index of their physical mixture. This is an indication that it has capacity to act as a sustained release agent. In another embodiment as exemplified under example 3, diclofenac tablets of 200 mg weight having diclofenac sodium (75 mg) are formulated using direct compression process with i) co-processed polymer (75 mg) and also ii) physical mixture of xanthan gum and guar gum. As noted in example 3, the physical mixture having the same concentrations of xanthan gum and guar gum could not sustain the release of the drug diclofenac sodium while the co-processed polymer in the same amounts produced sustained action over 8 to 10 hrs. Surprisingly the direct compression process has produced this action. This may eliminate the need of granulation and save processing time and cost of production.
The gums are used in oral films along with other film forming polymers. The film forming capacity of the co-processed polymer alone is tested. In another embodiment the film forming capacity of the co-processed polymer test as exemplified under example 4, oral films of Ondansetron hydrochloride were prepared. The co-processed polymer produced excellent oral films without use of any other polymer which dissolve in mouth instantly. These films released more than 85 % drug within 15 minutes and are stable.
The co-processed polymer also exhibits a gel forming capacity. The co-processed polymer in amounts from 0.5 to 5 % can be soaked in water for 2 to 8 hrs to produce gels. The soaked gel solution can be stirred to get desired homogeneity. Drug can be dissolved in alcohol or hydroalcoholic solution or water and added to such gel while stirring and the co-processed polymer (2 %) soaked for 4 to 5 hours produced excellent gel upon little stirring. In one embodiment as exemplified under example 5, a translucent gel of diclofenac sodium was produced having sufficient viscosity and spreadability.
The co-processed polymer has capacity of emulsification. The resultant emulsions prepared using the co-processed polymer of the present invention are stable and free of odour of oil. In an embodiment, the example 6 wherein an oil/water emulsion is prepared in which arachis oil is emulsified using co-processed polymer and such emulsion is found stable for four hours. Similarly stable water/oil emulsions using the co-processed polymer of the present invention can be prepared.
Thus, multifunctional polymer is successfully produced by co-processing two or more natural gums such as xanthan and guar gums preferably in a ratio of 1 : 1. This co-processed polymer differs significantly in properties from the two natural gums. It can act as binder, disintegrant, sustained release agent, film forming agent, gel forming agent, suspending agent, emulsifier and can have more roles to play. The co-processed polymers of the present invention serve as ideal excipients for use in excipient nutraceutical, pharmaceutical, biopharmaceutical, food, cosmetic, cosmeceutical, agrochemical compositions.
The co-processed polymers of the present invention can be used as such in variety of preparations or they can be admixed with other excipients such as cellulose, starch, lactose, mannitol and likes to prepare excipient mixtures which are further employed in variety of preparations. According to an embodiment, the process to prepare the co-processed polymer comprises 1) dispersing or dissolving two or more natural polysaccharides (gums or mucilages) in water 2) mixing the dispersion or solution till one gets a homogenous solution 3) precipitating the co-processed polymer using organic solvent selected from iso-propyl alcohol (IP A), ethanol and acetone 4) collecting and drying the precipitate and 5) optionally pulverizing the dried precipitate to get the desired co-processed polymer.
The process of preparation of the co-processed polymers is simple and economical. The process incorporates precipitation of the co-processed polymers by using solvent /anti-solvent method which imparts unique properties to the co-processed polymers. The process to prepare the co-processed polymers of two or more polysaccharides is performed at room temperature and thus has advantage over the hot melt method. Further, it is evident from the figures, fig. 1 and fig. 2 that there is no change in the chemical properties of the polysaccharides which confirms that there is no chemical interaction between the two polysaccharides. Thus, the process to prepare co-processed polymer according to the present invention merely changes the physical properties of individual gums in such a way that the resultant co- processed polymers exhibit beneficial physical properties and can be used as multifunctional excipient. The natural polysaccharide comprises gum or mucilage. The terms co-processed polymer or CPPor co-processed gum or CPG, as used herein, are interchangeably used and have the same meaning in the description. According to the present invention, the combination of gums used for making the co-processed polymer or co-processed gum is selected from the group comprising Xanthan gum and Guar gum (CPG XG), Xanthan gum and Acacia (CPG XA), Acacia and gum Karaya (CPG AK), Xanthan gum and gum Karaya (CPG XGKG), Guar gum and gum Karaya (CPG GK), Xanthan gum and gum Ghati (CPG XGh), Guar gum and gum Ghati (CPG GGh), Guar gum and Acacia (CPG GA) or gum Karaya and gum Ghati (CPG KGh).
According to another embodiment the co-processed polymer is selected from the group comprising co-processed polymer of Xanthan gum and Guar gum (CPG XG), co-processed polymer of Xanthan gum and Acacia (CPG XA), co-processed polymer of Acacia and gum Karaya (CPG AK), co-processed polymer of Xanthan gum and gum Karaya (CPG XGKG), co-processed polymer of Guar gum and gum Karaya (CPG GK), co-processed polymer of Xanthan gum and gum Ghati (CPG XGh), co-processed polymer of Guar gum and gum Ghati (CPG GGh), co- processed polymer of Guar gum and Acacia (CPG GA) or co-processed polymer of gum Karaya and gum Ghati (CPG KGh).
Various applications of the co-processed polymers of present invention and the approximate amount/range in which they can be used are as described in table 2.
Table 2
Figure imgf000010_0001
The drug which can be used for making oral disintegrating tablet is selected from the group comprising ondansetron hydrochloride, ibuprofen, lamotrigine, paracetamol, oxycodone, diclofenac, amlodipine, clonazepam, cetirizine, donepezil, risperidone, tramadol, alprazolam, carbidopa-levodopa, dipheniramine, prednisolone, zolmitriptan, selegiline, sildenafil citrate, vardenafil hydrochloride, tadalafil, mirtazapine, fexofenadine, imodium, famotidine, olanzapine, mirtazapine, loratadine, piroxicam, rizatriptan and likes. The drug which can be used for making sustained release tablet is selected from the group comprising aceclofenac, chlorpheniramine maleate, metoprolol succinate, lornoxicam, nifedipine, metformin hydrochloride, diclofenac, glipizide, venlaflaxine hydrochloride, divalproex sodium, tramadol hydrochloride, lithium carbonate, quetiapine fumarate, clarithromycin, tamsulosine hydrochloride, amitriptyline hydrochloride, oxcarbazepine, amisulpriden, pregabalin, ranolazine, progesterone, etodolac, lamotrigine, valsartan and likes.
The drug which can be used for making film is selected from the group comprising curcumin, phenylephrine, levocetrizine, elitriptan, nifedipine, pilocarpine, propranolol, losartan potassium, venlafaxine, lamotrigine, tramadol, hydrochlorthiazide, famotidine, ondansetran hydrochloride, isosorbide dinitrated omperidone, ropinirole, granisetron, amlodipine, Zolpidem or ivabradine hydrochloride and likes. Examples
Example 1:
Evaluation of co-processed polymer as binder
Formulation: Tablet prepared using XG, GG and the co-processed polymer (CPG).
Table 3 Formulation
Ingredients (mg) Fl F2 F3 F4 F5 F6
Venlafaxine 37.5 37.5 37.5 37.5 37.5 37.5
Microcrystalline cellulose (MCC) 56.5 56.5 56.5 56.5 56.5 56.5
PVP K30 4 — — — — —
Starch — 12 — — — —
XG (Xanthan Gum) — — 4 — — —
GG (Guar Gum) — — — 4 — —
XG+GG (PHY MIX) — — — — 4 —
CPG (Co-processed polymer of XG 4 and GG)
IPA (Isopropyl alcohol) q.s. q.s. q.s. q.s. q.s. q.s.
Magnesium stearate 1 1 1 1 1 1
Talc 1 1 1 1 1 1 q.s.: quantity sufficient Procedure:
Batches Fl, F3, F4, F5 and F6 were prepared by following method:
The drug, MCC and binder powder were weighed and thoroughly mixed. This mixture was then granulated by using IPA (q.s.) and granules were sieved through mesh size #10. Granules were dried in hot air oven at 50°C and then sieved through mesh size #20 and retained on mesh size #40. Magnesium stearate and talc were added. Tablets were punched on single press compression machine with 8 mm round, flat faced punch. Hardness was set around 4.
Preparation of Batch F2:
Drug and MCC weighed and thoroughly mixed. Starch paste (10%w/w) was added to bind the mixture and granules were sieved through mesh size #10. Quantity of starch powder in used starch paste was calculated. Granules were dried in hot air oven at 50° C and then sieved through mesh size #20 and retained on mesh size #40. Magnesium stearate and talc were added. Tablets were punched on single press compression machine with 8 mm round, flat faced punch. Hardness was set around 4.
Binding property:
Table 4
Figure imgf000013_0001
Conclusion: From this study it is noted that the individual counterparts viz. xanthan and guar gums lack good binding properties but their co-processed polymer in the same concentration enhanced disintegration time 4 folds indicating strong binding properties. CPG provides binding very similar to PVP-K30, a conventional binder. CPG can be used in much lesser amounts as compared to starch used in paste form.
Example 2
Evaluation of theco-processed polymer of XG and GG as disintegrating agent Formulation: Oral disintegrating tablet (ODT)
Table 5
Figure imgf000013_0002
Xanthan Gum (XG) — 20 — —
PHY MIX (XG+GG) — — 20 —
CPG XG and GG) — — — 20
Sodium saccharine 3 3 3 3
Flavour 2 2 2 2
Talc 2 2 2 2
Magnesium stearate 2 2 2 2
Procedure:
All the ingredients were weighed, mixed thoroughly and sieved through mesh size #40 to get a homogenous mixture. This mixture was directly compressed using single press compression machine with 9 mm flat faced punch. Hardness was set around 3.
Post compression evaluation:
Table 6
Figure imgf000014_0001
Conclusion: The formulation F10 prepared employing CPG showed good disintegrating property at 10% concentration.
The prepared formulation disintegrated completely in just 28 seconds indicating applicability of CPG as a disintegrant. It has been noted that the disintegration time of tablets prepared using CPG is comparable to that of PHY MIX with improved hardness which is essential for storage, handling and transportation.
Example 3 Evaluation of the co-processed polymer of xanthan gum and guar gum as sustained release agent
Formulation: Directly compressible sustained release (SR) tablet
Table 7
Figure imgf000015_0001
Procedure: All the ingredients were weighed, mixed thoroughly and sieved through mesh size #40 to get a homogenous mixture. This mixture was directly compressed using single press compression machine with 9 mm flat faced punch. Hardness was set around 5.
Dissolution was performed in paddle type apparatus, RPM 50, bath temperature 37 degrees, dissolution medium- 900 ml phosphate buffer pH 7.5.
Dissolution study of tablets:
Table 8
Figure imgf000015_0002
4 52.00 -
5 58.57 -
6 66.44 -
7 70.13 -
8 74.80 -
9 80.93 -
10 95.39 -
11 96.16 -
12 101.55 -
Conclusion: The CPG XG improves flow property thus ideal for direct compression of tablet. The tablets thus formed had good hardness and showed release upto 12 hours. Thus, using CPG wet granulation step can be avoided which is common for SR (sustained release) formulations. It can be concluded that physical mixture (PHY MIX ) of XG and GG is not suitable for direct compression SR tablets.
Example 4
Evaluation of the co-processed polymerof as film forming agent
Formulation: Film
Table 9
Figure imgf000016_0001
Properties of CPG:
Table 10
Figure imgf000017_0001
Dissolution study:
Dissolution was performed in paddle type apparatus, RPM 50, bath temperature 37 degrees, dissolution medium- 900 ml 0.1 N HCl.
Table 11A
Figure imgf000017_0002
Stability Data on Films
Figure imgf000017_0003
Conclusion: This study suggests that the co-processed polymer forms stable film as compared to the physical mixture of its counterparts. Also the film shows excellent dissolution properties. Example 5:
Evaluation of the co-processed polymer as gel forming agent
Procedure: CPG (2% w/w) solution in purified water was prepared by soaking the gum in water for 5 hours. This was then stirred a little to get homogenous consistency. Diclofenac sodium (l%w/w) was dissolved in ethanol (1 ml) and added to the gel base. Viscosity was measured using Brookfield viscometer, using spindle no. 7 at 20 RPM.
Table 12
Figure imgf000018_0001
Conclusion: This study suggests that the co-processed polymer has good gel forming capacity.
Example 6
Evaluation of the co-processed polymer as emulsifying agent
Formulation: Oil/water emulsion (O/W)
Table 13
Figure imgf000018_0002
Procedure: Arachis oil and CPG XG were triturated together in a ceramic mortar. Water was then added at once and pestle was moved vigorously in one direction till clicking sound was heard. Formed emulsion was kept for around 4 hours
Properties of Emulsion prepared using CPG:
Table 14
Figure imgf000019_0001
Conclusion: This study suggests that the co-processed polymer exhibits good emulsifying property.
Example 7
Evaluation of viscosity of the co-processed gum
The co-processed polymer is selected from the group comprising a co-processed polymer of Xanthan gum and Guar gum (CPG XG), co-processed polymer of Xanthan gum and Acacia (CPG XA), co-processed polymer of Acacia and gum Karaya (CPG AK), co-processed polymer of Xanthan gum and gum Karaya (CPG XK), co-processed polymer of Guar gum and gum Karaya (CPG GK), co-processed polymer of Xanthan gum and gum Ghati (CPG XGh), co-processed polymer of Guar gum and gum Ghati (CPG GGh), co-processed polymer of Guar gum and Acacia (CPG GA), co-processed polymer of gum Karaya and gum Ghati (CPG KGh) or co-processed polymer of Xanthan gum, Guar gum and Acacia (XGA). Viscosity studies of the co-processed polymers are performed on 0.05% w/w solution using Ostwald viscometer and the data is as in table 15 below.
Table 15 Sr.No. Viscosity (cps)
Co-processed Co-processed Physical mixture polymer polymer (CPG) (PHY MIX)
1 CPG AK 0.933859 0.782423
2 CPG XA 2.016 0.9081
3 CPG XK 0.984338 0.896000
4 CPG GK 1.123155 0.990316
5 CPG XGh 0.974596 0.785965
6 CPG GGh 1.226105 0.990316
7 CPG GA 1.839158 1.163228
8 CPG KGh 0.958877 0.911719
9 CPG XGA 1.116070 0.943158
From the above study it can be concluded that co-processed gum (CPG) gives more viscous solution than the physical mixture of two or more individual counterpart (PHY MIX). In other words lesser co-processed gum (CPG) will be required to impart same viscosity if compared with the quantity required by the counterparts.
Example 8
Evaluation of the co-processed polymer of Xanthan gum and Acacia (CPG XA) as emulsifying agent
Formulation: Emulsion
Table 16
Figure imgf000020_0001
Procedure: Arachis oil and CPG XA were triturated together in a ceramic mortar. Water was then added at once and pestle was moved vigorously in one direction till clicking sound was heard. Formed emulsion was kept for around 4 hours.
Emulsifying property:
Table 17
Figure imgf000021_0001
Conclusion: The co-processed polymer of CPG XA has good emulsifying property.
Example 9
Evaluation of the co-processed polymer of Acacia and gum Karaya (CPG AK) emulsifying agent
Formulation: Emulsion (O/W)
Table 18
Figure imgf000021_0002
Procedure: Arachis oil and CPG AK were triturated together in a ceramic mortar. Water was then added at once and pestle was moved vigorously in one direction till clicking sound was heard. Formed emulsion was kept for around 4 hours.
Emulsifying property
Table 19 Parameters Observation
Colour Buff coloured
Odour Characteristic
Texture Smooth
Consistency Creamy
Observation on standing No separation of oil observed
Conclusion: The co-processed polymer of CPG AK has good emulsifying property. Example 10
Evaluation of the co-processed polymer of Xanthan gum and gum Karaya (CPG XK) as emulsifying agent
Formulation: Emulsion (O/W)
Table 20
Figure imgf000022_0001
Procedure: Arachis oil and CPG XK were triturated together in a ceramic mortar. Water was then added at once and pestle was moved vigorously in one direction till clicking sound was heard. Formed emulsion was kept for around 4 hours.
Emulsifying Property
Table 21
Figure imgf000022_0002
Conclusion: The co-processed polymer of Xanthan gum and gum Karaya (CPG XK) has good emulsifying property.
Example 11
Evaluation of the co-processed polymer of Guar gum and gum Karaya (CPG GK) as gel forming agent
Formulation: Gel
Preparation: 2% w/w CPG GK gum solution in purified water was prepared by soaking the gum in water for 5 hours. This was then stirred a little to get homogenous consistency. Diclofenac sodium (1% w/w of the gel base) was dissolved in ethanol (1 ml) and added to the gel base. Viscosity was measured using Brookfield viscometer, using spindle no. 7 at 20 RPM.
Gel forming property:
Table 22
Figure imgf000023_0001
Conclusion: This study suggests that the co-processed polymer of Guar gum and gum Karaya (CPG GK) exhibits good gel forming capacity.
Example 12
Evaluation of the co-processed polymer of Xanthan gum and gum Ghati (CPG XGh) as disintegranting agent
Formulation: ODT of Lamotrigine prepared employing the co-processed polymer
Table 23 Formulation
Ingredients (mg) Fl F2 F3 F4
Lamotrigine 25 125 25 125
Mannitol 156 780 156 780
CPG 10 50 — —
PHY MIX — — 10 50
Sodium saccharine 3 15 3 15
Flavour 2 10 2 10
Talc 2 10 2 10
Mg stearate 2 10 2 10
Procedure: All the ingredients were weighed, mixed thoroughly and sieved through mesh size #40 to get a homogenous mixture. This mixture was directly compressed using single press compression machine with 9 mm flat faced punch. Hardness was set around 3.5.
Post compression evaluation:
Table 24
Figure imgf000024_0001
Conclusion: The co-processed polymer CPG XGh showed good disintegrating property at 5 % concentration. The prepared formulation disintegrated completely in just 25 seconds indicating applicability of CPG XGh as a disintegrant. It has been noted that the disintegration time of tablets prepared using CPG XGh is better than that of PHY XGh. Example 13
Evaluation of the co-processed polymer of Guar gum and gum Ghati (CPG GGh) as gel forming agent Formulation: Gel
Preparation: 2% w/w CPG GGh gum solution in purified water was prepared by soaking the gum in water for 5 hours. This was then stirred a little to get homogenous consistency. Diclofenac sodium (l%w/w of the gel base) was dissolved in 1 ml ethanol and added to the gel base. Viscosity was measured using Brookfield viscometer, using spindle no. 7 at 20 RPM.
Gel forming property:
Table 25
Figure imgf000025_0001
Conclusion: This study suggests that the co-processed polymer of Guar gum and gum Ghati (CPG GGh) exhibits good gel forming capacity.
Example 14
Evaluation of the co-processed polymer of Guar gum and Acacia (CPG GA)as gel forming agent
Formulation: Gel
Preparation: 2% w/w CPG GA gum solution in purified water was prepared by soaking the gum in water for 5 hours. This was then stirred a little to get homogenous consistency. Diclofenac sodium (l%w/w of the gel base) was dissolved in 1 ml ethanol and added to the gel base. Viscosity was measured using Brookfield viscometer, using spindle no. 7 at 20 RPM.
Gel forming property:
Table 26 Parameters CPG GA PHY MIX GA
PH 7 7
Consistency Viscous , gel like Viscous , gel like
Colour Translucent Translucent
Odour Odourless Odourless
Viscosity 7500 cps 2500 cps
Spreadability 3.58 2.76
% Assay 98.46 % 99.58 %
Conclusion: This study suggests that the co-processed polymer of Guar gum and gum Acacia (CPG GA) exhibits good gel forming capacity.
Example 15
Evaluation of the co-processed polymer of gum Karaya and gum Ghati (CPG KGh) as emulsifying agent
Formulation: Emulsion (O/W)
Table 27
Figure imgf000026_0001
Procedure: Arachis oil and CPG KGh were triturated together in a ceramic mortar. Water was then added at once and pestle was moved vigorously in one direction till clicking sound was heard. Formed emulsion was kept for around 4 hours.
Emulsifying property:
Table 28 Parameters Observation
Colour Brown coloured
Odour Characteristic
Texture Smooth
Consistency Creamy
Observation on standing No separation of oil observed
Conclusion: The co-processed polymer of gum Karaya and gum Ghati (CPG KGh) has good emulsifying property. Example 16
Evaluation of the co-processed polymer of Xanthan gum, Guar gum and Acacia (CPG XGA) as disintegranting agent
Formulation: ODT of Lamotrigine prepared employing the co-processed polymer
Table 29
Figure imgf000027_0001
Procedure: All the ingredients were weighed, mixed thoroughly and sieved through mesh size #40 to get a homogenous mixture. This mixture was directly compressed using single press compression machine with 9 mm flat faced punch. Hardness was set around 3.5.
Post compression evaluation: Table 30
Figure imgf000028_0001
Conclusion: The co-processed polymer of Xanthan gum, Guar gum and Acacia (CPG XGA) showed good disintegrating property at 5 % concentration. The prepared formulation disintegrated completely in just 19 seconds indicating applicability of CPG XGA as a disintegrant. It has been noted that the disintegration time of tablets prepared using CPG XGA is better than that of PHY MIX XGA.

Claims

We claim,
1. Co-processed polymer comprising two or more natural polysaccharides possessing at least one significantly enhanced physical property from its counterpart components.
2. The co-processed polymer as claimed in claim 1 wherein said physical property is one or more of flow properties, disintegration property, compressibility, binding property, property to enhance hardness, viscosity, swelling property, gelling property, emulsifying property, film forming property, sustained release property.
3. The co-processed polymer as claimed in claim 1 wherein said polysaccharide is gum or mucilage selected from the group comprising Guar gum, Xanthan gum, Acacia gum, Karaya gum, Gum Ghatti, Locust bean gum, Okra gum, Albizia gum, Tara gum, Cassiatora,Cordia, Taro, Konjac, Isabgol mucilage, Phoenix mucilage, Jackfruit gum, Tamarind seed polysaccharide, Fenugreek mucilage, Honey locust gum, Mimosa scrabella, Mimosa pudica, Ocimum mucilage, Gum rosin, Black gram, Gulmohar mucilage, Almond gum, Cashew gum, Moringaoleifera gum, Gum damar, Gum Copal, Kondagogu Gum, Bhara gum, Hakea gum, Grewia gum, Olibanum gum, Terminalia gum, Cocculus mucilage, Aloe mucilage, Hibiscus mucilage, Neem gum, Moi gum, Konjacglucomannan, Curdlan gum, Gellan gum, Colanic acid or K30 antigen.
4. The co-processed polymer as claimed in claim 1 wherein said polysaccharides are used in the ratio from 1: 10 to 10: 1.
5. The co-processed polymer as claimed in claim 1 is used as bulking agent, binder, disintegrating agent, emulsifying agent, film forming agent, gel forming agent, sustained release agent, viscosity enhancer and swelling agent.
6. The co-processed polymer as claimed in claim 1 to 5 wherein said copolymer with enhanced properties is suitable for use in preparing excipient, nutraceutical, pharmaceutical, biopharmaceutical, food, cosmetic, cosmeceutical, agrochemical compositions.
7. The co-processed polymer as claimed in claim 6 wherein said preparation is selected from pill, lozenge, tablet, capsule, oral disintegrating table, sustained release tablet or capsule, dispersible tablets, sachet preparations, films, gel, emulsion, cream, powder for suspension or solutions.
8. Composition comprising co-processed polymer of two or more natural polysaccharides.
9. A process to prepare the co-processed polymer of two or more polysaccharides comprising the steps of a) dispersing or dissolving two or more polysaccharides in first solvent b) mixing the dispersion or solution to get a homogenous solution c) precipitating the co-processed polymer using second solvent d) collecting and drying the precipitate and e) optionally pulverizing the dried precipitate to get the co-processed polymer.
10. The process as claimed in claim 8 wherein said first solvent is water and said second solvent is organic solvent selected from iso-propyl alcohol, ethanol or acetone.
PCT/IN2016/050244 2015-07-20 2016-07-19 Process of preparation of co-processed polymer and it's pharmaceutical application WO2017013682A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2730MU2015 2015-07-20
IN2730/MUM/2015 2015-07-20

Publications (1)

Publication Number Publication Date
WO2017013682A1 true WO2017013682A1 (en) 2017-01-26

Family

ID=57834762

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2016/050244 WO2017013682A1 (en) 2015-07-20 2016-07-19 Process of preparation of co-processed polymer and it's pharmaceutical application

Country Status (1)

Country Link
WO (1) WO2017013682A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109394718A (en) * 2018-11-15 2019-03-01 石药集团中诺药业(石家庄)有限公司 A kind of amoxicillin dispersible tablet and preparation method thereof
CN114369031A (en) * 2021-12-24 2022-04-19 阜阳欣奕华材料科技有限公司 Synthetic method of 4, 4' -diamino terphenyl
CN114957509A (en) * 2022-08-01 2022-08-30 深圳柏垠生物科技有限公司 Scalable purification method of kola acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IKONI J OGAJI ET AL.: "Advances in Natural Polymers as Pharmaceutical Excipients", PHARMACEUTICA ANALYTICA ACTA, vol. 3, 18 January 2012 (2012-01-18), pages 146, XP055348403 *
SUNIL GOSWAMI ET AL.: "Natural gums and its pharmaceutical application", JOURNAL OF SCIENTIFIC AND INNOVATIVE RESEARCH 2014, vol. 3, no. 1, 23 February 2014 (2014-02-23), pages 112 - 121, XP055348405 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109394718A (en) * 2018-11-15 2019-03-01 石药集团中诺药业(石家庄)有限公司 A kind of amoxicillin dispersible tablet and preparation method thereof
CN109394718B (en) * 2018-11-15 2021-04-27 石药集团中诺药业(石家庄)有限公司 Amoxicillin dispersible tablet and preparation method thereof
CN114369031A (en) * 2021-12-24 2022-04-19 阜阳欣奕华材料科技有限公司 Synthetic method of 4, 4' -diamino terphenyl
CN114369031B (en) * 2021-12-24 2024-04-12 阜阳欣奕华材料科技有限公司 Synthesis method of 4,4' -diaminoterphenyl
CN114957509A (en) * 2022-08-01 2022-08-30 深圳柏垠生物科技有限公司 Scalable purification method of kola acid

Similar Documents

Publication Publication Date Title
EP0223590B1 (en) Substained release compositions comprising hydroxypropyl cellulose ethers
AU2007234864B2 (en) Fast release paracetamol tablets
NO342239B1 (en) Pregelatinized starch in a controlled release formulation
JPS62149632A (en) Solid medicine
JP6706245B2 (en) Directly compressible composition containing microcrystalline cellulose
WO2002017848A1 (en) Hard capsule
WO2000022008A1 (en) Polymer combining with phosphoric acid and preparation containing the same
JPH08504214A (en) Konjac glucomannan readily available as a modified release excipient
Rahman et al. Formulation and evaluation of Ranolazine sustained release matrix tablets using Eudragit and HPMC
JP2012531415A (en) Cross-linked polyallylamine tablet core
AU706699B2 (en) Extended-release solid oral dosage forms of drugs having low solubility in water
CN101380290A (en) Novel controlled release-niacin formulation
WO2017013682A1 (en) Process of preparation of co-processed polymer and it's pharmaceutical application
CN101022808B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
CN102137663A (en) Stable pharmaceutical formulation with limited discoloration
JPH0513132B2 (en)
JP2686215B2 (en) Sustained-release tablets
Ghule et al. Evaluation of Binding Properties of Evaluation of Binding Properties of Eulophia campestris Wall. Mucilage all. Mucilage
Akin-Ajani et al. Development of directly compressible excipients from Phoenix dactylifera (Date) mucilage and microcrystalline cellulose using co-processing techniques
JP4370050B2 (en) Clarithromycin tablets and method for producing the same
Eraga et al. Evaluation of fast disintegrating tablets of paracetamol prepared from a blend of croscarmellose sodium and Pleurotus tuber-regium powder
EP0266707A2 (en) Sustained release labetalol tablet
Afrose et al. A strategic design improvement in patient-centric sustained delivery of metoprolol succinate using natural gum blend matrix: design, development and in-vitro comparative evaluation
Shetty et al. Design and evaluation of sustained release matrix tablets of etodolac
Ismail et al. Formulation and in vitro evaluation of once-daily methyldopa sustained release matrix tablets

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16827386

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16827386

Country of ref document: EP

Kind code of ref document: A1